2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$49.56-$0.94 (-1.85%)
Price as of Oct 22, 2026 7:56 PM EDT- $5.0BMarket Cap
- -24.08%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$49.56-$0.94 (-1.85%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $50.50 | ||
Change | +$0.62 (+1.24%) | ||
Open | $50.13 | ||
High | $50.94 | ||
Low | $49.55 | ||
Previous Close | $49.88 | ||
Volume | 1,171,127 | ||
30-Day Average Volume | 1,605,070 | ||
1-Week Change | 0.56% | ||
1-Month Change | -13.42% | ||
1-Year Change | -24.08% | ||
3-Year Change | 30.76% | ||
5-Year Change | -47.97% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.0B | ||
Enterprise Value | $5.3B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$91.2M | ||
Free Cash Flow | -$84.1M | ||
EBIT | -$86.9M | ||
EBITDA | -$82.6M | ||
Net Working Capital | $2.2B | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -64 | ||
Enterprise Value/Revenue | 527 | ||
P/B | 3 | ||
P/E | -54 | ||
PEG | -2 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue